BrainJuicer’s (BJU) interims were in line with pre-close guidance. To meet broadly unchanged FY15 expectations, despite being behind H114, depends on strong trading in the final few weeks of the year (as is normal). Costs incurred in shifting the qualitative offer (15% revenue) to a new Brand Strategy service, together with one-off costs relating to property moves and an aborted acquisition, held back H1 profits but improved the overall commercial positioning. The current EV/EBITDA valu
28 Sep 2015
Waiting to crank up the growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Waiting to crank up the growth
BrainJuicer’s (BJU) interims were in line with pre-close guidance. To meet broadly unchanged FY15 expectations, despite being behind H114, depends on strong trading in the final few weeks of the year (as is normal). Costs incurred in shifting the qualitative offer (15% revenue) to a new Brand Strategy service, together with one-off costs relating to property moves and an aborted acquisition, held back H1 profits but improved the overall commercial positioning. The current EV/EBITDA valu